AIM3 Ventures and Southern Sun Pharma Welcome Inaugural Legislation Legalizing Cbd IN South Africa
AIM3 VENTURES AND SOUTHERN SUN PHARMA WELCOME INAUGURAL LEGISLATION
LEGALIZING CBD IN SOUTH AFRICA
TORONTO, May 27, 2019 -- AIM3 Ventures Inc. ( TSXV:AIMC.P) ("AIM3") and Southern Sun
Pharma Inc., (“Southern Sun ” or the “Company”), a leading Africa-focused cannabis
company, welcome inaugural legislation in South Africa, resulting in the first federally
approved market for non-prescription CBD in Africa. Following a change to South Africa’s
Medicines and Related Substances Act last week, South Africa became the first country in
Africa to legalise cannabidiol use.
Southern Sun CEO Warren Schewitz stated, “We are delighted to receive this positive
development in the medical Cannabis legalization process in South Africa. This is a landmark
piece of legislation, enabling wide scale access to CBD products. As a pioneer in the African
cannabis sector, Southern Sun Pharma has been preparing for advancements such as these
for some time. We will imminently be in a position to share our progress relating to the supply
of premium CBD products from local and international sources.”
About AIM3 Ventures
AIM3 was incorporated under the Business Corporations Act (Ontario) and is a Capital Pool
Company (as defined in the policies of the TSXV) listed on the TSXV. AIM3 has no commercial
operations and no assets other than cash.
About Southern Sun
Southern Sun Pharma, a Canadian registered company, is a multi-licence holder with a
dedicated focus on Africa. The company was formed by experienced entrepreneurs with a
proven track record of building significant shareholder value both in Africa and North
America. Southern Sun is focussing on significantly lower cost production opportunities in
Africa to support its plan to distribute and supply both the local cannabis market and export
markets with a focus on countries in near proximity to its headquarters in South Africa.
Cautionary Note Regarding Forward-Looking Information
This press release contains statements which constitute "forward-looking information" within
the meaning of applicable securities laws, including statements regarding the plans,
intentions, beliefs and current expectations of AIM3 and Southern Sun with respect to future
business activities and operating performance. Forward-looking information is often identified
by the words "may", "would", "could", "should", "will", "intend", "plan", "anticipate",
"believe", "estimate", "expect" or similar expressions (i) the business plans and expectations
of the Company including; and (ii) expectations for other economic, business, and/or
competitive factors.
Investors are cautioned that forward-looking information is not based on historical facts but
instead reflect AIM3 and Southern Sun's respective management's expectations, estimates or
projections concerning future results or events based on the opinions, assumptions and
estimates of management considered reasonable at the date the statements are made.
Although AIM3 and the Company believe that the expectations reflected in such forward-
looking information are reasonable, such information involves risks and uncertainties, and
undue reliance should not be placed on such information, as unknown or unpredictable factors
could have material adverse effects on future results, performance or achievements of AIM3
or the Company. Among the key factors that could cause actual results to differ materially
from those projected in the forward-looking information are the following: changes in general
economic, business and political conditions, including changes in the financial markets;
changes in the perception and demand for cannabis in both local and export markets; changes
in applicable laws and regulations both locally and in foreign jurisdictions; compliance with
extensive government regulation and the costs associated with compliance; costs of building
and developing projects and product opportunities; and the risks and uncertainties associated
with foreign markets. This forward-looking information may be affected by risks and
uncertainties in the business of AIM3 and the Company and market conditions.
Should one or more of these risks or uncertainties materialize, or should assumptions
underlying the forward-looking information prove incorrect, actual results may vary materially
from those described herein as intended, planned, anticipated, believed, estimated or
expected. Although AIM3 and the Company have attempted to identify important risks,
uncertainties and factors which could cause actual results to differ materially, there may be
others that cause results not to be as anticipated, estimated or intended and such changes
could be material. AIM3 and the Company do not intend, and do not assume any obligation,
to update this forward-looking information except as otherwise required by applicable law.
Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of
the TSXV) accepts responsibility for the adequacy or accuracy of this release.
SOURCE AIM3 Ventures Inc.
For further information: please contact:
AIM3 Ventures Inc.
Zachary Goldenberg, Chief Executive Officer
E-mail: [email protected]
Phone: 647-987-5083
Southern Sun Pharma Inc.
Warren Schewitz
E-mail: [email protected]
Phone (+27) 82 040 7274